The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dissecting primary endocrine resistance through ctDNA profiling of a hybrid real-world and clinical trial dataset in hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC).
 
Lorenzo Gerratana
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Incyte; Lilly; Menarini Group; Merck Sharp & Dohme; Novartis; Pfizer
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Menarini Group; Novartis
 
Carmine De Angelis
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Novartis; Pfizer
 
Fabiola Giudici
No Relationships to Disclose
 
Alessandro La Torraca
Employment - Roche
 
Vincenzo Montesarchio
No Relationships to Disclose
 
Simona Gasparro
No Relationships to Disclose
 
Laura Biganzoli
Honoraria - Boehringer Ingelheim; Exact Sciences; Lilly; MSD; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Genomic Health; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen
Research Funding - Celgene (Inst); Genomic Health (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; MSD
 
Silvia Castellani
Employment - Roche
 
Emilia Sicari
Employment - Roche
 
Lorenzo Foffano
No Relationships to Disclose
 
Roberto Buonaiuto
No Relationships to Disclose
 
Paola Lucia Poletti
No Relationships to Disclose
 
Carminia Maria Della Corte
No Relationships to Disclose
 
Giuseppina Ricciardi
No Relationships to Disclose
 
Giuseppe Cairo
No Relationships to Disclose
 
Teresa Gamucci
No Relationships to Disclose
 
Lucia Del Mastro
Honoraria - Gilead Sciences; Lilly; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Ipsen; Lilly; Menarini; MSD; Novartis; Olema Oncology; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Olema Oncology; Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Roche
 
Mario Giuliano
No Relationships to Disclose
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Italfarmaco; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Viatris
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Amgen; Astrazeneca; Celgene; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pfizer; Roche
 
Grazia Arpino
Honoraria - AstraZeneca; Lilly; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - Helsinn Therapeutics/QED Therapeutics; Lilly; Novartis; Pfizer; Roche
Research Funding - eisai (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Lilly; Pfizer; Roche